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ABSTRACT 
Timothy syndrome 1 (TS1) is a rare genetic disorder characterized by multisystem 
abnormalities including QT prolongation, congenital heart defects, facial dysmorphism, 
episodic hypoglycemia and neurological symptoms. A morphological hallmark of TS1 is 
syndactyly, present in all cases. TS1 is caused by the canonical p.Gly406Arg mutation in the 
alternatively spliced exon 8A in the CACNA1C gene, encoding for the main cardiac L-type 
calcium channel. A variant case of TS1 is reported. The proband had intermittent fetal 
bradycardia with heart rate of 72 bpm. On the first day of life bradycardia due to 2:1 
atrioventricular (AV) block and marked QTc prolongation of 600 ms was noted. On medical 
therapy with propranolol and mexiletine 1:1 AV conduction returned with QTc prolongation 
of 470-580 ms. The patient lacked other extracardiac manifestations, most importantly 
syndactyly, neurological complications or autism. On genetic analysis, the canonical TS1 
causing mutation, p.Gly406Arg in exon 8A of the CACNA1C gene was detected. The 
CACNA1C p.Gly406Arg variant was not present in the parents, but was detected in the buccal 
DNA sample of the index patient. Our case highlight further phenotypic variability in TS. 
Most importantly, it underlines that the lack of syndactyly does not exclude the presence of a 
TS1 genotype. 
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INTRODUCTION 
Timothy syndrome (TS) is a very rare genetic disorder which is characterized by numerous 
multisystem abnormalities leading to clinically two distinct forms of the syndrome (reviewed 
in [Liao and Soong 2010]). Timothy syndrome 1 (TS1) is characterized by QT prolongation, 
congenital heart defects (including patent ductus arteriosus, patent foramen ovale, and 
ventricular septal defect), facial dysmorphisms (including a flat nasal bridge, small upper jaw, 
low-set ears, or small and misplaced teeth), episodic hypoglycemia and neurologic symptoms 
including developmental delays, autism, seizures, and intellectual disability [Splawski et al. 
2004]. A morphological hallmark of TS1 is syndactyly, which is reported to be present in 
100% of the cases (Table 1) [An et al. 2013; Corona-Rivera et al. 2015; Dufendach et al. 
2013; Ergul et al. 2015; Etheridge et al. 2011; Krause et al. 2011; Lo et al. 2005; Splawski et 
al. 2004]. Timothy syndrome 2 (TS2) patients have no syndactyly but carry the other 
multisystem manifestations of the disease [Diep and Seaver 2015; Frohler et al. 2014; 
Hiippala et al. 2015; Philipp and Rodriguez 2016; Splawski et al. 2005]. Because of extreme 
QT prolongation, individuals with TS can experience ventricular tachycardia/fibrillation 
(VT/VF) and cardiac arrest, and the overall complications of multisystem abnormalities often 
lead to early death. 
The predominant genetic cause of TS1, identified in 2004 [Splawski et al. 2004], was 
a recurrent, canonical ‘de novo’ heterozygous missense mutation, p.Gly406Arg, in the 
alternatively spliced exon 8A in the CACNA1C gene, encoding for the main cardiac L-type 
calcium channel, Cav1.2. In cases with TS2, 2 additional mutations, p.Gly406Arg and 
p.Gly402Ser, were identified in exon 8 of the CACNA1C gene [Splawski et al. 2005]. Exons 8 
and 8A of the CACNA1C gene undergo alternative splicing in a mutually exclusive manner, 
with exon 8 being the predominantly expressed isoform. Recently some other mutations, all 
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affecting the CACNA1C gene, were reported in TS patients [Boczek et al. 2015; Gillis et al. 
2012; Wemhoner et al. 2015]. 
Here we report a variant case of Timothy syndrome, named Timothy syndrome 1.1, 
manifested as neonatal 2:1 AV block and marked QT prolongation. Genetic analysis revealed 
a CACNA1C gene exon 8A p.Gly406Arg mutation, thereby defining the case as Timothy 
syndrome 1 on genetic grounds. However, the patient lacks many of the other hallmarks of 
TS1, most notably syndactyly, and also other major extracardiac manifestations.  
PATIENT AND METHODS 
Clinical report 
The proband was born as a second child to a healthy 31-year-old woman and 31-year-old 
man, both of Caucasian descent. There was no report of consanguinity, and the family 
histories were non-contributory. Especially, family history was negative for premature sudden 
cardiac death, arrhythmic disorders, syndactyly, facial dysmorphism or autism. The 
pregnancy was uncomplicated. Intermittent fetal bradycardia (heart rate of 72 bpm) was noted 
at 37 weeks gestation. The baby was born via normal uncomplicated vaginal delivery at 38 
weeks gestation. Apgar scores were 9 and 10 at one and 5 minutes, respectively. The baby’s 
birth weight was 2950 g (18th centile), length was 54 cm (98th centile), and head 
circumference measured 34 cm (35th centile). On the second day of life cardiac evaluation 
revealed bradycardia due to 2:1 atrioventricular (AV) conduction and marked QTc-interval 
prolongation of 600 ms (Figure 1, Panel A). On medical therapy (propranolol and mexiletine) 
QTc duration stabilized in the range of 470-580 ms; 2:1 AV conduction resolved, and there 
was consistent 1:1 AV conduction with T-wave alternans (Figure 1, Panel B). Initial imaging 
with echocardiography demonstrated a patent foramen ovale, with a diameter of 2.5 mm with 
left-to-right shunt, and a mildly dilated right ventricle. The Botall duct was closed and there 
were no signs of ventricular septal defect, cardiomyopathy or ventricular dysfunction. 
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Laboratory findings did not reveal hypoglycemia or hypocalcaemia. The patient did not have 
facial dysmorphisms (hypertelorism, flattened nasal bridge, prominent forehead, etc.) and was 
not bald. He did not have joint hypermobility. Most importantly no syndactyly, either on the 
hands or on the feet, were present (Figure 1, Panel C and D). No hypoplastic teeth and decay 
was noted. During his first three years of life he has made steady developmental progress. He 
sat unassisted at age 7.5 months, crawled at age 8 months, walked with support at age 8.5 
months and walked independently at age 12 months. First words were at age 14 months. At 
age 2 years an M-CHAT (Modified Checklist for Autism in Toddlers) test was done which 
did not indicate autism or autism spectrum disorder. He does not have frequent or serious 
infections. As the patient’s father is a board certified cardiologist, he is under continuous bed-
side ECG monitoring during nights with frequent traditional Holter monitoring performed in 
every 3-6 month. Only at one occasion a 2:1 AV conduction was detected for 12 hours, 
without symptoms, but no sustained or non-sustained ventricular tachyarrhythmias were ever 
encountered. 
At age 2 years he was hospitalized because of an episode of severe hypoglycemia 
(blood glucose level 1.4 mmol/l) associated with convulsions. As head trauma could not be 
excluded, a cranial CT was performed under general anesthesia. No VT or VF was observed 
under medication with propofol, midazolam, fentanyl and muscle relaxants. The only 
observed rhythm disturbance was an intermittent 2:1 AV block which returned to normal 
conduction after the correction of serum glucose levels. The episode resolved without any 
further consequence. Glucose monitoring with tissue glucose sensor did not reveal any further 
episode of hypoglycemia in the subsequent days. At present, at age 3 years, his mental and 
physical development seems to be undisturbed. He is in a good general health and attends 
kindergarten without assistance. He is able to express feelings, understands jokes and sadness. 
Molecular genetic analysis 
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The investigations were approved by the Institutional Ethics Committee of the University of 
Szeged, and conducted according to the Helsinki declaration. Family members and the 
patient’s care-givers gave prior written informed consent to the molecular genetic analysis. 
Coding sequences and exon-intron boundaries of all 13 causative long QT genes were 
analyzed by next-generation sequencing using Agilent’s SureSelect technology with custom-
designed 120-mer RNA baits specific to target region (Agilent Technologies, Santa Clara, 
CA, United States). Targeted resequencing was carried out on a SOLiD 5500xl System (Life 
Technologies, Grand Island, NY, United States). Variants, identified by targeted 
resequencing, were validated by standard capillary sequencing using custom-designed 
primers. Exon 37 of ANK2 gene, exon 8A of CACNA1C gene, and exon 1 of KCNQ1 gene 
were direct-sequenced on a ABI Prism 310 Genetic Analyzer (Applied Biosystems by Life 
Technologies, Grand Island, NY, United States). Genetic mosaicism was assessed in the index 
patient and both parents using DNA extracted from buccal cells and from sperm, in case of 
father. 
Mapping of the SOLiD reads were accomplished by Genomic Workbench ver 7.0.3 (CLC 
Bio, now part of Qiagen) using the human genome assembly hg19 as reference sequence. 
Variant calling and variant annotation were performed by the same software. The functional 
impact of amino acid changes caused by missense mutations was predicted by SIFT and 
PROVEAN programs. Nucleotide and amino acid changes are reported according to the 
Ensembl database (release: 85), based on reference sequences ENST00000155840.9 for 
KCNQ1, ENST00000399591.5 for CACNA1C and ENST00000264366.10 for ANK2. 
RESULTS 
Mutation data 
Three different heterozygous genetic variants in three genes have been detected using targeted 
resequencing by next-generation sequencing: p.Gly406Arg (c.1216G>A, rs79891110) in exon 
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8A of the CACNA1C gene (Figure 2); p.Tyr94Cys (c.281A>G, rs781717051) in exon 1 of the 
KCNQ1 gene; and p.Ile3252Thr (c.9755T>C, rs36210417) in exon 37 of the ANK2 gene. All 
three variants were previously reported. The KCNQ1 p.Tyr94Cys variant was predicted to be 
deleterious by PROVEAN and to be tolerant by SIFT. The ANK2 p.Ile3252Thr variant was 
predicted to be neutral/tolerant by both prediction methods. The identified CACNA1C gene 
exon 8A p.Gly406Arg variant is the canonical Timothy syndrome 1 causing mutation. 
Although sequence homology is high between exons 8 and 8A of the CACNA1C gene, the 
presence of several “exon specific” nucleotides made possible to distinguish between the two 
(Figure 2). Sequence comparison with all available published sequences of CACNA1C exon 8 
and 8A in previous reports proved that our patient indeed carried the p.Gly406Arg variant 
affecting exon 8A of the CACNA1C gene. The CACNA1C p.Gly406Arg variant was also 
present in the DNA sample of the index patient extracted from buccal cells. The height of the 
mutant nucleotide peak was similar in both samples and were equal to the normal nucleotide 
peak (Figure 2). 
Family screening 
First degree family members of the index patient (mother, father and sister) underwent genetic 
screening for all three variants. The proband’s father was proved to be carrier of the KCNQ1 
p.Tyr94Cys variant, while mother and sister were non-carriers for both the KCNQ1 and ANK2 
variants. Neither the parents nor the sister of the index patient carried the CACNA1C 
p.Gly406Arg variant (Figure 2), therefore this variant must have arisen ‘de novo’ (paternity 
was proven). The KCNQ1 p.Tyr94Cys variant-carrying father has no signs or symptoms of 
long QT syndrome and has a completely normal ECG and echocardiogram (data not shown), 
suggesting that the KCNQ1 p.Tyr94Cys variant has no major influence on the disease 
phenotype. 
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In order to assess whether the CACNA1C Gly406Arg mutation is indeed arisen ‘de 
novo’ in the family, or one of the parents has mosaicism for the mutation, we performed 
genetic analysis of the DNA extracted from buccal cells (in case of both parents) and sperm 
(in case of father). The CACNA1C Gly406Arg variant was not present in any sample extracted 
from different tissues, therefore no proof for genetic mosaicism was found (data not shown). 
DISCUSSION 
Here we report a variant case of Timothy syndrome, referred to as Timothy syndrome 1.1, 
caused by a TS1-specific CACNA1C exon 8A p.Gly406Arg mutation. The clinical phenotype 
was characterized by neonatal 2:1 AV block and marked QT prolongation. However, the 
patient lacked many of the other hallmarks of TS1, most notably syndactyly, and no other 
major extracardiac manifestations were present. 
Syndactyly is reported in 100% of patients with CACNA1C exon 8A p.Gly406Arg 
mutation (Table 1). Moreover, syndactyly was also present in patients proved to be somatic or 
germline mosaic carriers of the mutation [Dufendach et al. 2013; Etheridge et al. 2011]. In 
one of these cases the direct presence of the CACNA1C exon 8A p.Gly406Arg mutation was 
demonstrated in left/right arm skin biopsy samples with an estimated percent mosaicism of 
∼6.5% [Dufendach et al. 2013]. As Cav1.2 was highly expressed in apical ectodermal ridge 
cells of developing digits, syndactyly is thought to be caused in TS by Ca2+-induced cell death 
in the apical ectodermal ridge [Splawski et al. 2004]. 
The most probable explanation for the lack of syndactyly and major extracardiac 
manifestations in our case is the presence of somatic mosaicism in our patient. The mutant 
Cav1.2 channel must be absent from unaffected organs (limbs, brain) and might be present in 
low levels in probably affected organs (heart, pancreas) in our patient. However, as we had 
only two sources of tissue (lymphocytes, buccal cells), and both were shown to harbor the 
mutation, direct evidence for the above explanation is lacking.  
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Reports on mosaic patients with TS1 describe a partial phenotype of the disease, 
similar to ours. These patients are usually parents of a more severely affected proband with 
genetically confirmed mosaicism with the potential to transmit the TS1-causative mutation to 
their offspring, resulting in fully expressive TS1. Dufendach et al reported a mosaic female 
patient who had right-sided syndactyly and was the mother of a newborn boy who presented 
with syndactyly, extreme QT prolongation and 2:1 atrioventricular block during syndactyly-
corrective surgery [Dufendach et al. 2013]. The mother didn’t have evidence of QT 
prolongation or other TS1 manifestation. In a report by Etheridge et al. two TS1 mosaic 
patients were described [Etheridge et al. 2011]. One was the father of a patient with TS1 in 
whom mosaicism was detected. The father had complete cutaneous syndactyly of the right 
and left feet, but had no other dysmorphic features. He was cognitively normal and never had 
syncope or seizure. ECG demonstrated a prolonged QTc of 480 ms. The other patient was a 
14-year-old girl who had a cardiac arrest with documented ventricular fibrillation that 
occurred while making a phone call. She had a prolonged QTc interval of 560 ms and bilateral 
syndactyly involving the hands and the feet, but no other manifestation of TS1. The possible 
presence of somatic mosaicism was also reported with regard to TS2 [Hiippala et al. 2015; 
Splawski et al. 2005]. 
In conclusion, we described a Timothy syndrome 1 genotype without syndactyly and 
major extracardiac manifestations. The case highlight further phenotypic variability in 
Timothy syndrome. Most importantly, it underlines that the lack of syndactyly doesn’t 
exclude the presence of Timothy syndrome 1 genotype. 
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Figure 1. 12-lead ECG of the proband illustrating 2:1 AV block and marked QTc-interval 
prolongation of 600 ms at a heart rate of 72 bpm (Panel A). On medical therapy (propranolol 
and mexiletine) 2:1 AV conduction resolved, and there is a consistent 1:1 AV conduction with 
QTc prolongation of 516 ms with T-wave alternans at a heart rate of 123 bpm (Panel B). 
Paper speed 25 mm/s, calibration 10 mm/mV. Panel C and D: Photograph of the proband’s 
hands and feet, at age 12 months, demonstrating no syndactyly of the fingers or toes. 
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Figure 2. Sequence analysis of exon 8A of the CACNA1C gene illustrating the c.1216G>A 
mutation. The mutation changes the GGA triplet at codon 406, encoding for glycine, to AGA, 
encoding for arginine (p.Gly406Arg). Sequencing result is shown from DNA isolated from 
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blood (patient, father, mother) and from buccal cells (patient). Testing of parents suggested 
that the mutation is ‘de novo’. Nucleotides framed in red are unique for exon 8A when 
compared to homologous exon 8. 
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Table 1. Clinical and genetic characteristics of Timothy syndrome patients with proven genetic diagnosis reported in the literature. 
 
Report 
reported 
pts. (n) 
TS 
type 
affected 
CACNA1C 
exon 
CACNA1C 
mutation 
QT interval and 
arrhythmia 
additional cardiac 
phenotype 
main additional symptoms 
Splawski et al, 
20042 
13 TS1 8A Gly406Arg 
QT prolongation 
(100%), VT (71%), 
bradycardia, AV 
block (94%) 
PDA (59%), PFO 
(29%), VSD (18%), 
cardiomegaly 
(35%) 
autism/autism spectrum 
disorder (60-80%), bald at 
birth (100%), small teeth 
(100%), recurrent infections 
(43%), facial dysmorphia 
(53%) 
Lo-A-Njoe et 
al, 20059 
2 TS1 8A Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, VT 
HCM, PDA, HF fetal hydrops 
Krause et al, 
20118 
1 TS1 8A Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, VT 
HCM, VSD, PDA lower set ears and bald head 
Etheridge et al, 
20117 
2 TS1 8A Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, VT 
VSD 
widely spaced eyes, broad 
forehead, wide nasal bridge, 
broad nasal tip 
Dufendach et 
al, 20135 
1 TS1 8A Gly406Arg 
QT prolongation, 
bradycardia, AV 
block 
none  
An et al, 20133 1 TS1 8A (9)* Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, CA 
none 
round face, small upper jaw 
and teeth, nearly bald head 
Corona-Rivera 
et al, 20154 
1 TS1 8A Gly406Arg 
QT prolongation, AV 
block 
PDA, PFO fetal hydrops 
Ergül et al, 
20156 
1 TS1 8A Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, CA 
PDA, PFO 
neuro-motor development 
retardation, facial dysmorphia 
Splawski et al, 
200514 
1 TS2 8 Gly406Arg 
QT prolongation, 
bradycardia, AV 
block, VT, CA 
HCM, biventricular 
dysfunction 
mental retardation, nemaline 
myopathy, facial dysmorphia, 
seizures 
Splawski et al, 
200514 
1 TS2 8 Gly402Ser 
QT prolongation, VT, 
CA 
HCM 
facial dysmorphia, recurrent 
infections 
Fröhler et al, 
201411 
2 TS2 8 Gly402Ser 
QT prolongation, VT, 
CA 
none no 
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Hiippala et al, 
201412 
1 TS2 8 Gly402Ser 
QT prolongation 
(mild), CA 
none no 
Diep et al, 
201510 
1 TS2 8 Gly406Arg 
QT prolongation, AV 
block, VT 
PDA, PFO 
hypotension, metabolic 
acidosis, recurrent apnea, 
seizure-like activity, poor 
growth, facial dismorphia 
Philipp et al, 
201613 
1 TS2 8 Gly406Arg 
QT prolongation, AV 
block, VT, CA 
PDA, biventricular 
systolic dysfunction 
intermittent hypoglycemia, 
hypocalcemia 
Gillis et al, 
201217 
1 TS 38 Ala1473Gly 
QT prolongation, AV 
block, VT 
PDA, PFO 
facial dysmorphism, 
contractures, episodes of 
hypoglycemia, hypocalcemia, 
seizures, cortical blindness, 
developmental delay 
Boczek et al, 
201516 
1 TS 27 Ile1166Thr 
QT prolongation, AV 
block 
PDA, biventricular 
dysfunction 
seizures, cerebral and 
cerebellar atrophy, facial dys- 
morphism, clinodactyly, 
respiratory failure 
Wemhöner et 
al, 201518 
1 TS 27 Ile1166Thr QT prolongation, CA PDA, HCM developmental delay 
 
TS: Timothy syndrome; PDA: patent ductus arteriosus; PFO: patent foramen ovale; VSD: ventricular septal defect; HCM: hypertrophic cardiomyopathy; VT: 
ventricular tachycardia; AV: atrio-ventricular; CA: cardiac arrest 
*reported as exon 9, but based on direct sequence comparison it corresponds to exon 8A 
 
